141 related articles for article (PubMed ID: 10502582)
1. Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.
Nishida K; Quantock AJ; Dota A; Choi-Miura NH; Kinoshita S
Br J Ophthalmol; 1999 Oct; 83(10):1178-82. PubMed ID: 10502582
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
Zlokovic BV
Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
[TBL] [Abstract][Full Text] [Related]
3. Alterations of epithelial adhesion molecules and basement membrane components in lattice corneal dystrophy (LCD).
Resch MD; Schlötzer-Schrehardt U; Hofmann-Rummelt C; Kruse FE; Seitz B
Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1081-8. PubMed ID: 19190930
[TBL] [Abstract][Full Text] [Related]
4. Clinical, histopathologic, and ultrastructural characteristics of BIGH3(TGFBI) amyloid corneal dystrophies are supportive of the existence of a new type of LCD: the LCDi.
Schmitt-Bernard CF; Schneider C; Argilés A
Cornea; 2002 Jul; 21(5):463-8. PubMed ID: 12072720
[TBL] [Abstract][Full Text] [Related]
5. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.
Golabek A; Marques MA; Lalowski M; Wisniewski T
Neurosci Lett; 1995 May; 191(1-2):79-82. PubMed ID: 7659297
[TBL] [Abstract][Full Text] [Related]
7. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
8. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.
Bertrand P; Poirier J; Oda T; Finch CE; Pasinetti GM
Brain Res Mol Brain Res; 1995 Oct; 33(1):174-8. PubMed ID: 8774959
[TBL] [Abstract][Full Text] [Related]
9. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
[TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein J (clusterin) and Alzheimer's disease.
Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
[TBL] [Abstract][Full Text] [Related]
13. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
Cole GM; Ard MD
Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.
DeMattos RB; Brendza RP; Heuser JE; Kierson M; Cirrito JR; Fryer J; Sullivan PM; Fagan AM; Han X; Holtzman DM
Neurochem Int; 2001; 39(5-6):415-25. PubMed ID: 11578777
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein J and Alzheimer's amyloid beta solubility.
Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
[TBL] [Abstract][Full Text] [Related]
16. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
[TBL] [Abstract][Full Text] [Related]
17. Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion.
White F; Nicoll JA; Horsburgh K
Exp Neurol; 2001 Jun; 169(2):307-18. PubMed ID: 11358444
[TBL] [Abstract][Full Text] [Related]
18. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
[TBL] [Abstract][Full Text] [Related]
19. Keratoepithelin in secondary corneal amyloidosis.
Suesskind D; Auw-Haedrich C; Schorderet DF; Munier FL; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):725-31. PubMed ID: 16331487
[TBL] [Abstract][Full Text] [Related]
20. Raman Spectroscopic Study of Amyloid Deposits in Gelatinous Drop-like Corneal Dystrophy.
Acri G; Micali A; D'Angelo R; Puzzolo D; Aragona P; Testagrossa B; Aragona E; Wylegala E; Nowinska A
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
